Advertisement
JBC

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Originally published In Press as doi:10.1074/jbc.M506275200 on July 22, 2005

J. Biol. Chem., Vol. 280, Issue 38, 32594-32601, September 23, 2005
This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
280/38/32594    most recent
M506275200v1
Right arrow Submit a Letter to Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Zhang, Y.-M.
Right arrow Articles by Jackowski, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Zhang, Y.-M.
Right arrow Articles by Jackowski, S.
Social Bookmarking
Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Feedback Regulation of Murine Pantothenate Kinase 3 by Coenzyme A and Coenzyme A Thioesters*

Yong-Mei Zhang, Charles O. Rock, and Suzanne Jackowski1

From the Department of Infectious Diseases, St. Jude Children's Research Hospital, Memphis, Tennessee 38105

Received for publication, June 8, 2005 , and in revised form, July 8, 2005.


   ABSTRACT
TOP
 ABSTRACT
INTRODUCTION
 EXPERIMENTAL PROCEDURES
 RESULTS
 DISCUSSION
 REFERENCES
 
Pantothenate kinase catalyzes a key regulatory step in coenzyme A biosynthesis, and there are four mammalian genes that encode isoforms of this enzyme. Pantothenate kinase isoform PanK3 is highly related to the previously characterized PanK1{beta} isoform (79% identical, 91% similar), and these two almost identical proteins are expressed most highly in the same tissues. PanK1{beta} and PanK3 had very similar molecular sizes, oligomeric form, cytoplasmic cellular location, and kinetic constants for ATP and pantothenate. However, these two PanK isoforms possessed distinct regulatory properties. PanK3 was significantly more sensitive to feedback regulation by acetyl-CoA (IC50 = 1 µM) than PanK1{beta} (IC50 = 10 µM), and PanK3 was stringently regulated by long-chain acyl-CoA (IC50 = 2 µM), whereas PanK1{beta} was not. Domain swapping experiments localized the difference in the two proteins to a 48-amino-acid domain, where they are the most divergent. Consistent with these more stringent regulatory properties, metabolic labeling experiments showed that coenzyme A (CoA) levels in cells overexpressing PanK3 were lower than in cells overexpressing an equivalent amount of PanK1{beta}. Thus, the distinct regulatory properties exhibited by the family of the pantothenate kinases allowed the rate of CoA biosynthesis to be controlled by regulatory signals from CoA thioesters involved in different branches of intermediary metabolism.


   INTRODUCTION
TOP
 ABSTRACT
 INTRODUCTION
EXPERIMENTAL PROCEDURES
 RESULTS
 DISCUSSION
 REFERENCES
 
Pantothenate is the essential precursor for CoA,2 which is a cofactor for a multitude of metabolic reactions including the oxidation of fatty acids, carbohydrates, pyruvate, lactate, ketone bodies, and amino acids, as well as many synthetic reactions. PanK catalyzes the first committed step and is the rate-controlling enzyme in CoA biosynthesis in bacteria (1) and mammals (2). PanK expression levels define the upper threshold of the cellular CoA content (3, 4), and PanK biochemical activity is feedback-regulated by CoA and/or CoA thioesters (3, 5–8), providing a mechanism to coordinate the rate of CoA synthesis with metabolic demand. Loss of feedback regulation by mutation at a single residue results in runaway CoA production (9). A notable exception to this rule is the PanK from Staphylococcus aureus, which lacks CoA feedback regulation (10), consistent with a role for CoA as the primary thiol in the disulfide redox system in this organism, as well as being the major acyl-group carrier (11–13). In mammals, PanK activity and/or CoA content are altered in response to metabolic state (14–18), insulin (2), glucagon or glucocorticoids (15), fibrates (14, 19–22), or diabetes (23, 24). CoA is found in all cellular compartments, but the highest concentrations of CoA exist in mitochondria and peroxisomes (25, 26). Mitochondrial CoA is used as a cofactor in the tricarboxylic acid cycle and fatty acid {beta}-oxidation, and the concentrations of CoA and its thioesters regulate the rates of these processes (27). Peroxisomes play a major role in very long chain fatty acid {beta}-oxidation and also have high concentrations of CoA (28, 29), most of which appears to be bound to matrix components (30).

The discovery of multiple isoforms of PanK encoded by four genes in humans (31–34) and mice (5, 35) suggests a complexity associated with diet-, drug-, or disease-induced responses of PanK expression and activity. All PanK isoforms have a common catalytic core that is defined by the primary structures of PanK1{beta} and PanK3 (5) (see Fig. 1). PanK1{alpha} and PanK2 possess amino-terminal extensions to this core, which, in the case of PanK1{alpha}, alters the sensitivity of the protein to feedback inhibition (5), and in the case of PanK2, specifies its subcellular localization to the mitochondria (33, 36, 37). PanK4 has a long carboxyl-terminal extension of unknown function. PanK1{alpha} and PanK1{beta} arise from alternate initiation exons in the Pank1 gene (5, 32). Human PANK1{alpha} and -1{beta} proteins are located in the cytoplasm, and PANK1{alpha} mRNA expression and activity are stimulated by bezafibrate administration, resulting in elevated CoA (32). Mouse PanK1{alpha} and -1{beta} isozymes are most highly expressed in liver and have distinct regulatory properties and are differentially controlled by CoA and acetyl-CoA (5). The human PANK2 gene encodes a precursor protein that undergoes sequential cleavage at two positions to produce a final product localized to the mitochondria (33, 36, 37). The inherited PanK-associated neurodegenerative disorder was recently linked to mutations in the human PANK2 gene (31). PanK-associated neurodegenerative disorder patients have a pathological accumulation of iron in the basal ganglia and a combination of motor symptoms in the form of dystonia, dysarthria, intellectual impairment, and gait disturbance (38). Interestingly, the mouse knock-out of the Pank2 gene gives rise to several phenotypes including retinal degeneration; however, the iron accumulation and dystonia associated with human PANK2 mutations are not observed (39). Little is known about the PanK3 and PanK4 species beyond the identification of their cDNAs and the RNA expression pattern. The PANK3 gene is most highly expressed in liver, whereas the PANK4 transcript is highest in muscle (31).

The focus of this work is to characterize the biochemical properties of PanK3 in comparison with the known PanK1{beta} isozyme. PanK3 and PanK1{beta} have very highly related primary sequences (see Fig. 1), and northern blot analysis shows that the PanK1 and PanK3 isoforms are most highly expressed in liver (3, 36). On the surface, there is no obvious explanation for why there are two apparently identical proteins expressed in the same tissue. The co-expression of these isoforms in liver suggested that they may play different roles in diet- and drug-induced alterations in CoA levels or in the regulation of intermediary metabolism. Our work revealed that the regulation of PanK3 was distinctly different from previously characterized isoforms in eukaryotes. PanK3 was significantly more sensitive to feedback regulation by CoA and CoA thioesters than the other isozymes that are highly expressed in liver, PanK1{alpha}, and PanK1{beta}.


   EXPERIMENTAL PROCEDURES
TOP
 ABSTRACT
 INTRODUCTION
 EXPERIMENTAL PROCEDURES
RESULTS
 DISCUSSION
 REFERENCES
 
Preparation of Pantothenate Kinases—The mouse PanK1{beta} expression vector was described previously (5). The mouse cDNAs homologous to the human PanK1{beta} (5) and PanK3 proteins (31) were cloned into pcDNA3.1(–) (Invitrogen) to generate plasmids pRC63 and pPJ218, respectively. The two PanK chimeras, namely, PanK3-1{beta}-3 and PanK1{beta}-3-1{beta}, were constructed using overlap extension PCR, in which the sequences encoding the 48-residue region indicated in Fig. 1 were replaced in either PanK1{beta} or PanK3 by the corresponding sequence of the other isoform, yielding plasmids pKM59 and pKM58, respectively. Both strands of the chimeric cDNAs were completely sequenced and checked correct.

The PanK proteins were overexpressed in HEK 293T cells (from Dr. Suzanne Baker, St. Jude Children's Research Hospital) cultured in Dulbecco's modified Eagle's medium and 10% fetal calf serum (Atlanta Biologicals) following transfection with FuGENE 6 according to the manufacturer's recommendations (Roche Applied Science). Cells were collected 48 h after transfection, washed with phosphate-buffered saline, and resuspended in hypotonic lysis buffer (10 mM Tris-HCl, pH 7.5, 1 mM EDTA, 10 mM NaF, and 5 µg/ml leupeptin). After incubation on ice for 1 h, cells were lysed by sonication. The lysate was centrifuged at 5,000 x g for 5 min at 4 °C to remove the unbroken cells and nuclei. The supernatant was stored in 50% glycerol at –20 °C. Protein concentrations were determined by the method of Bradford (40) using {gamma}-globulin as a standard.

The whole liver of a 4-month-old male C57BL6/J mouse was harvested and homogenized in 2.5 ml of 20 mM potassium phosphate buffer containing 1 mM ATP. The total homogenate was centrifuged at 20,000 x g for 45 min at 4 °C. The resultant supernatant was dialyzed overnight against the homogenization buffer at 4 °C. The protein concentration in the dialyzed liver lysate was determined by the Bradford assay (40).

Western Blot Detection of PanK Protein—A peptide SKDNYKRVTGTSLGC was synthesized and coupled to keyhole limpet hemocyanin by the Hartwell Center for Biotechnology, St. Jude Children's Research Hospital, and was sent to Rockland Inc. (Gilbertsville, PA) for raising rabbit polyclonal antiserum against all PanK isoforms except PanK4. Affinity purification of the polyclonal antibody was performed as described previously (5, 41). HEK 293T cells were transfected and lysed using hypotonic lysis buffer as described above. Aliquots of the crude cell lysate from transfected cells were fractionated by SDS-PAGE on 10% NuPAGE® Novex Bis-Tris gels (Invitrogen). The separated proteins were electroblotted onto a polyvinylidene difluoride membrane, and the PanK isoforms were detected by PanK-specific antibody at a dilution of 1:500 (stock is 1.4 mg/ml), which was incubated with the membrane for 1 h at room temperature. Horseradish peroxidase-labeled anti-rabbit IgG was used as the secondary antibody and was diluted to 1:5,000 prior to incubation with the membrane for 1 h at room temperature. The blots were washed five times with 100 ml of Tris-buffered saline-Tween 20 and developed using the ECF detection reagents according to the manufacturer's instructions (Amersham Biosciences). The fluorescent signal was detected using a Typhoon 9200 (Amersham Biosciences) and analyzed with ImageQuant 5.2 (Amersham Biosciences).

Pantothenate Kinase Assays—Briefly, the standard pantothenate kinase assays (5, 9) contained D-[1-14C]pantothenate (90 µM; specific activity 55 mCi/mmol; Amersham Biosciences), ATP (2.5 mM, pH 7.0), MgCl2 (10 mM), Tris-HCl (0.1 M, pH 7.5), and the indicated amount of cell extract or column fraction containing PanKs in a total volume of 40 µl. The mixture was incubated at 37 °C for 10 min. The reaction was stopped by adding 4 µl of 10% (v/v) acetic acid to the mix, and then 40 µl of the mixture was deposited onto a Whatmann DE81 ion-exchange filter disk that was washed in three changes of 1% acetic acid in 95% ethanol (25 ml/disk) to remove unreacted pantothenate. 4'-Phosphopantothenate was quantitated by counting each dried disk in 3 ml of scintillation fluid.

Metabolic Labeling—HEK 293T cells were transfected with either a control plasmid without an insert (pcDNA3.1) or plasmids expressing either PanK1{beta} (pRC63) or PanK3 (pPJ218) and incubated for 18 h. The medium was then changed to pantothenate-free Dulbecco's modified Eagle's medium containing 10% dialyzed calf serum and 2 µM [1-14C]pantothenate. The cells were labeled for 4 or 8 h, harvested, and washed twice with phosphate-buffered saline. The cell pellet was lysed by sonication in 20 mM Tris-HCl, pH 7.5, 2 mM dithiothreitol, 5 mM EDTA, 50 mM NaF. Cell debris was removed by centrifugation and aliquots were removed for determination of protein and total [1-14C]pantothenate incorporated into the cell. The identity of the intracellular metabolites was determined by fractionating the cell lysates by thin-layer chromatography on Silica Gel H plates developed with butanol:acetic acid:water (5:2:3) using the standards described previously (1). Sections (0.5 cm) were scraped from the plate, and the radioactivity quantitated using a liquid scintillation counter.

RT-PCR Analysis—Total RNA was isolated from male mouse liver using TRIzol reagent according to the manufacturer's instructions. Pelleted RNA was resuspended in nuclease-free water, digested with DNase I to remove any contaminating genomic DNA, aliquoted, and reprecipitated in ethanol and stored at –20 °C. Reverse was performed using SuperScriptTM II RNase H– transcription reverse transcriptase (Invitrogen), the RNA template, and random primers to make the corresponding cDNAs. For conventional RT-PCR, multiplex PCR amplification and detection were performed as described previously (42) using isoform-specific primers to confirm the absence or presence of expression. Quantitative real-time PCR of the PanK isoforms was performed using the ABI Prism® 7700 sequence detection system using primers and probes listed in TABLE ONE. The Taqman Rodent glyceraldehyde-3-phosphate dehydrogenase control reagent (Applied Biosystems) was the source of the primers and probe for quantitating the control glyceraldehyde-3-phosphate dehydrogenase mRNA. RNA was isolated from three mouse livers, and each RNA sample was quantified in quintuplicate. All of the real-time values were compared using the CT method, in which the amount of target RNA (2–{Delta}{Delta}CT) was normalized to the PanK1{alpha} reference ({Delta}CT), which was set as the calibrator at 1.0.


View this table:
[in this window]
[in a new window]
  		TABLE ONE
Primers and Probes for mouse PanK RT-PCR

6-FAM, 6-carboxyfluorescein; BHQ1, black hole quencher 1.

 



View larger version (49K):
[in this window]
[in a new window]
  		FIGURE 1.
Comparison of PanK1{beta} and PanK3 coding sequences. The predicted amino acid sequences of the proteins encoded by murine PanK1{beta} and PanK3 mRNAs are compared. The two proteins are 79.2% identical and 91.4% similar. The arrows delineate the boundaries used in the domain swapping experiments to generate the PanK1{beta}-3-1{beta} and PanK3-1{beta}-3 chimeras.

 
Gel Filtration Chromatography—The Stokes radii of PanK1{beta} and PanK3 TM were compared using gel filtration chromatography on a Superdex 200 10/300 GL column (Amersham Biosciences) equilibrated with 20 mM Tris-HCl, pH 7.4, 300 mM NaCl, 1 mM {beta}-mercaptoethanol, and 1 mM dithiothreitol. Protein molecular mass markers (Amersham Biosciences) were: ferritin (440 kDa); catalase (232 kDa); bovine serum albumin (66 kDa); ovalbumin (43 kDa); chymotrypsinogen A (25 kDa); RNaseA (13.7 kDa).


   RESULTS
TOP
 ABSTRACT
 INTRODUCTION
 EXPERIMENTAL PROCEDURES
 RESULTS
DISCUSSION
 REFERENCES
 
Expression and Activity of PanK3—PanK1{beta} and PanK3 are highly related proteins encoded by separate genes. These two enzymes are 79.2% identical and 91.4% similar (Fig. 1). The predicted monomer molecular sizes are 41.6 kDa for PanK1{beta} and 41.1 kDa for PanK3. The two full-length cDNAs were cloned into the pcDNA3.1(–) expression vector and transfected into 293T cells. In both cases, pantothenate kinase activity detected in the cell lysates increased significantly based on the biochemical assay, and all of the increased activity was detected in the soluble fraction (Fig. 2A). The specific activities of the two proteins were nearly identical under the standard assay conditions. These comparisons were facilitated by immunoblotting with the anti-pantothenate kinase antibody, which recognizes an epitope common to both PanK3 and PanK1{beta}. PanK activity was normalized to the amount of PanK protein expression based on the quantification of the western blot signal as described under "Experimental Procedures."

Kinetic Constants and Oligomeric State of PanK3 and PanK1{beta}—One possible difference in these two proteins may be their fundamental kinetic constants for ATP and pantothenate; therefore, we determined these values for both of the proteins. PanK3 had a Km for ATP of 112 ± 27 µM and a Km for pantothenate of 9.5 ± 1 µM. Under the same experimental conditions, PanK1{beta} exhibited a Km for ATP of 87 ± 31 µM and a Km for pantothenate of 5.7 ± 0.5 µM. These data illustrated that these fundamental catalytic properties of the two enzymes were very similar.

We also examined the Stokes radii of the two PanK isoforms to determine whether there was a difference in their oligomeric states (Fig. 2B). Both proteins eluted at identical positions on the Superdex 200 column at a location that was consistent with their existence as dimers in solution. Although this technique does not provide unequivocal information on the multimeric state of proteins, other pantothenate kinases are dimers (6, 10, 36), and this appears to be the most common functional organization for this group of enzymes. There was no evidence for structural differences between the two enzymes.

Feedback Regulation of PanK3—A hallmark feature of pantothenate kinases is that they are negatively regulated by CoA and/or its thioesters. Therefore, we performed a series of experiments with different CoA thioesters to determine whether PanK3 and PanK1{beta} differed in their regulatory properties (Fig. 3). PanK1{beta} was inhibited by acetyl-CoA (IC50 = 10 µM) and modestly by malonyl-CoA (IC50 > 100 µM) (Fig. 3A). In contrast, PanK1{beta} was refractory to feedback inhibition by both CoA and palmitoyl-CoA. The regulatory properties of PanK3 were clearly different (Fig. 3B). PanK3 was more sensitive to acetyl-CoA (IC50 = 1 µM) and malonyl-CoA (IC50 = 8 µM) and was modestly inhibited by free CoA (IC50 > 100 µM). The most striking difference between the two proteins was the stringent regulation of PanK3 by palmitoyl-CoA (IC50 = 2 µM), which was in sharp contrast to the inability of palmitoyl-CoA to affect the activity of PanK1{beta}.

Expression of PanK3 and PanK1 mRNA in Mouse Liver—Northern blot analysis of mouse tissues showed that both PanK3 and PanK1 were most abundantly expressed in both liver and kidney (3, 31). Thus, these two isoforms were most abundantly expressed in the same tissues, but the available data do not provide information about the relative levels of PanK1 and PanK3 expression in a single tissue. Liver apparently has the highest expression of both isoforms, and we performed real-time RT-PCR to quantify the levels of the PanK isoform mRNAs in this tissue (Fig. 4A). Clearly, the PanK1{alpha} isoform was the most highly expressed in male mouse liver. PanK1{beta} and PanK3 were present at approximately the same level and were half as abundant as PanK1{alpha}. These data suggested that about 25–30% of the pantothenate kinase protein in liver cytosol was PanK3 and 70–75% was PanK1{alpha} + PanK1{beta} and that the PanK1{alpha}: PanK1{beta}:PanK3 ratio was 2:1:1. PanK2 was expressed at about 18% the level of PanK1. The PanK2 isoform is associated with mitochondria (33, 36) and was therefore not located in the same cellular compartment as PanK1 and PanK3. PanK4 was expressed at the lowest level, and the function and location of this isoform are unknown. These data showed that the PanK1{alpha}, PanK1{beta}, and PanK3 isoforms were the most abundant PanKs expressed in male mouse liver cytosol.

We took advantage of the fact that PanK3 was refractory to CoA inhibition to design an experiment with mouse liver cytosol to estimate the percentage of total PanK activity attributable to this isoform. CoA was titrated into the PanK assay using mouse liver cytosolic extracts until the inhibition of activity was complete (Fig. 4B). Approximately 25% of the total liver PanK activity was refractory to CoA inhibition. Since PanK1{alpha} and PanK3 are inhibited by free CoA, the CoA-independent activity was attributed to the amount of PanK1{beta} in the extract. Thus, this biochemical experiment sets the level of PanK1{beta} as 25% of the total PanK, a finding that is consistent with the PanK1{beta} mRNA abundance determined by quantitative RT-PCR (Fig. 4A).



View larger version (24K):
[in this window]
[in a new window]
  		FIGURE 2.
Specific activity and oligomeric state of PanK3 and PanK1{beta}. A, PanK1{beta} (•) and PanK3 ({circ}) were expressed in 293T cells, and the soluble extracts were assayed for total protein and PanK enzymatic activity, and the data were normalized to the PanK1{beta} or PanK3 expression levels determined by western blot (inset) using an anti-pantothenate kinase antibody as described under "Experimental Procedures." Endogenous PanK activity in cells transfected with the empty vector ({blacksquare}) was insignificant in this protein concentration range. B, the Stokes radii of PanK1{beta} (•) and PanK3 ({circ}) were compared using gel filtration chromatography. PanK activity was localized using the standard assay format on column fractions. The monomer molecular sizes of PanK3 and PanK1{beta} were both {approx}41 kDa, and their oligomeric state in solution was estimated to be {approx}85.8 kDa (dimer) by graphic analysis of a standard curve based on the elution volumes of protein molecular markers (inset).

 



View larger version (19K):
[in this window]
[in a new window]
  		FIGURE 3.
Feedback regulation of PanK3 by CoA thioesters. A, comparison of the sensitivity of PanK1{beta} with feedback regulation by acetyl-CoA ({blacksquare}), malonyl-CoA (Mal-CoA, {square}), CoA ({circ}), and palmitoyl-CoA (Pal-CoA, •) in vitro. B, sensitivity of PanK3 to feedback regulation by acetyl-CoA ({blacksquare}), malonyl-CoA ({square}), CoA ({circ}), and palmitoyl-CoA (•) in vitro.

 
Control of Cellular CoA Levels by PanK3 Expression—We performed a steady-state metabolic labeling experiment to determine whether the feedback regulation of PanK3 was also more stringent than PanK1{beta} in vivo. Plasmids expressing either the PanK3 (pPJ218) or PanK1{beta} (pRC63) cDNAs or a control plasmid without an insert (pcDNA3.1(–)) were transfected into 293T cells, and 18 h later, the cultures were labeled with 2 µM [1-14C]pantothenate. Transfected cells were labeled to equilibrium, which was achieved by 4 h. The cells were harvested, and the effect of PanK expression on CoA levels was determined by chromatographic analysis of the intracellular pantothenate-derived metabolites. An example of this analysis at the 8 h time point is shown in Fig. 5. In the control cells, pantothenate was the major intracellular metabolite, with CoA and 4'-phosphopantetheine comprising 8.1 and 5.3% of the pool, respectively (Fig. 5A). This result was anticipated (3) and illustrated that the utilization of pantothenate was the limiting step. Expression of PanK1{beta} led to the elimination of intracellular pantothenate and the accumulation of CoA (73.5%) and 4'-phosphopantetheine (26.5%), illustrating that increased levels of PanK1{beta} drove the accumulation of intracellular CoA (Fig. 5B). The cells transfected with the PanK3 construct had an intermediate metabolic phenotype (Fig. 5C). Pantothenate remained a significant component of the intracellular pool (50.6%), but CoA was also appreciably elevated to 42.7% of the total pool. When these alterations in pool sizes at 4 and 8 h were averaged and normalized to cellular protein, there were distinctly different metabolite pool sizes in cells expressing the two proteins. PanK1{beta} expression increased the total pantothenate uptake 4-fold, and the intracellular CoA levels increased 33-fold (Fig. 6). Concomitant with the elevation of CoA, 4'-phosphopantetheine increased 24-fold in the PanK1{beta}-transfected cells. In contrast, total pantothenate incorporation into cells expressing PanK3 increased 1.5-fold but only resulted in a 7.6-fold increase in CoA (Fig. 6). The 4'-phosphopantetheine increased a more modest 1.8-fold. Significantly, the levels of intracellular pantothenate in PanK3-transfected cells were the same as in the controls, whereas pantothenate was absent from the PanK1{beta}-transfected cell population. This observation suggested that the total intracellular CoA was limited by pantothenate availability in the PanK1{beta}-expressing cells, but in the PanK3-expressing cells, the CoA content was limited by the activity of PanK3. These marked differences were not due to differences in the level of protein expression as judged by western blot analysis (Fig. 6, inset), but rather, were attributed to the more stringent feedback regulation of the PanK3 isoform.



View larger version (15K):
[in this window]
[in a new window]
  		FIGURE 4.
PanK isozyme expression in mouse liver. A, levels of PanK isoform mRNAs were determined in male mouse liver by RT-PCR, normalized to the glyceraldehyde-3-phosphate dehydrogenase mRNA, and then expressed relative to the PanK1{alpha} isoform. Primers, probes, and analysis are described under "Experimental Procedures." B, inhibition of total PanK activity in mouse liver cytosol by CoA. The specific activity at 100% was 23.3 pmol/min/mg of protein.

 



View larger version (16K):
[in this window]
[in a new window]
  		FIGURE 5.
Distribution of pantothenate-derived metabolites in cells transfected with PanK1{beta} and PanK3 expression constructs. Transfected 293T cells were labeled with 2 µM[1-14C]pantothenate for 8 h and lysed, and then the metabolites were separated, and the distribution of radioactivity was quantified by thin-layer chromatography on Silica Gel H layers developed with butanol:acetic acid:water (5:2:3) as described under "Experimental Procedures." A, 293T cells transfected with the empty control vector.B, 293T cells transfected with plasmid pCR63 expressing PanK1{beta}.C, 293T cells transfected with plasmid pPJ218 expressing PanK3.Metabolites were identified by co-migration with standards as described previously (1). Pan, pantothenate; P-PanSH, phosphopantetheine.

 
Structural Determinants of Feedback Regulation—The comparison of the primary sequences of PanK1{beta} and PanK3 indicated that they were most divergent in a 48-residue-amino-acid patch located within the amino-terminal domain (Fig. 1). We investigated whether this region contributed to the different regulatory properties of the proteins by generating and analyzing the catalytic and regulatory properties of chimeric proteins, in which the 48-residue region was swapped between the two proteins (Fig. 7). Both chimeras were expressed and had specific activities that were about 50% of their wild-type counterparts. The PanK1{beta}-3-1{beta} chimera gained the ability to be inhibited by palmitoyl CoA (Fig. 7A), whereas the PanK3-1{beta}-3 chimera lost its sensitivity to this regulatory ligand (Fig. 7B). PanK1{beta} and PanK3 also differ significantly in their response to acetyl-CoA (Fig. 3); therefore, we also examined the response of the chimeras to this ligand. The PanK1{beta}-3-1{beta} chimera was more sensitive to acetyl-CoA inhibition than PanK1{beta} (Fig. 7C), and the PanK3-1{beta}-3 chimera became more resistant to acetyl-CoA (Fig. 7D). These data illustrated that the 48-residue domain influenced the ability of both palmitoyl- and acetyl-CoA to block PanK activity.



View larger version (37K):
[in this window]
[in a new window]
  		FIGURE 6.
Regulation of intracellular CoA levels by PanK3. The amounts of intracellular pantothenate-derived metabolites were normalized to total cellular protein and compared in control cells and in cells transfected with either PanK3 or PanK1{beta} expression vectors. Data for 4 and 8 h, after steady-state labeling was achieved, are combined. The levels of PanK1{beta} and PanK3 expression were determined by western blotting with an anti-pantothenate kinase antibody (inset).

 



View larger version (18K):
[in this window]
[in a new window]
  		FIGURE 7.
Sensitivity of chimeric proteins to feedback regulation by CoA thioesters. Wild-type and chimeric proteins were expressed in 293T cells, and soluble cell extracts were prepared and assayed for PanK activity in the presence of the indicated concentrations of palmitoylor acetyl-CoA as described under "Experimental Procedures." A, inhibition of PanK1{beta} ({circ}) and the PanK1{beta}-3-1{beta} chimera (•) by palmitoyl-CoA. B, inhibition of PanK3 ({square}) and the PanK3-1{beta}-3 chimera ({blacksquare}) by palmitoyl-CoA. C, inhibition of PanK1{beta} ({circ}) and the PanK1{beta}-3-1{beta} chimera (•) by acetyl-CoA. D, inhibition of PanK3 ({square}) and the PanK3-1{beta}-3 chimera ({blacksquare}) by acetyl-CoA. The location of the domain swapped in these experiments is indicated in Fig. 1.

 

   DISCUSSION
TOP
 ABSTRACT
 INTRODUCTION
 EXPERIMENTAL PROCEDURES
 RESULTS
 DISCUSSION
REFERENCES
 
The major cytosolic pantothenate kinase isoforms, PanK1{alpha}, PanK1{beta}, and PanK3, differ significantly in their sensitivity to feedback inhibition by CoA thioesters, thus allowing CoA biosynthesis to receive regulatory signals from different branches of intermediary metabolism. PanK1{beta} is insensitive to inhibition by CoA and palmitoyl-CoA but is inhibited by acetyl-CoA (IC50 = 10 µM). PanK1{alpha} respond to higher concentrations of CoA (IC50 = 80 µM) and lower concentrations of acetyl-CoA (IC50 = 5 µM) and palmitoyl-CoA (IC50 = 30 µM). PanK3 was more sensitive to CoA thioester regulation than either of the PanK1 isoforms, and acetyl-CoA (IC50 = 1 µM) and palmitoyl-CoA (IC50 = 2 µM) were equipotent regulators. Like PanK1{alpha}, PanK3 responded weakly to CoA (IC50 > 100 µM). The significance of the regulatory properties of PanK3 and PanK1{beta} determined in vitro became apparent in vivo, both in cultured cells and in liver. CoA biosynthesis in cells following enforced expression of either of these two isoforms reflected their sensitivities to feedback inhibition. Although PanK3 expression increased the intracellular CoA levels, it was not nearly as effective as the expression of a similar amount of PanK1{beta}, reflecting the in vitro observation that PanK3 activity is more stringently controlled by components of the CoA pool (Figs. 5 and 6). In male liver cytosolic extracts, ~25% of the total PanK activity is refractory to inhibition by CoA (Fig. 4B), corresponding to the relative expression level of PanK1{beta} (Fig. 4A), which is insensitive to CoA inhibition (Fig. 3A). Quantitative RT-PCR analysis of male mouse liver mRNA indicates that the ratio of PanK1{alpha}:PanK1{beta}:PanK3 is 2:1:1 (Fig. 4A). PanK1{beta} and PanK3 are nearly identical in primary sequence, are most highly expressed in liver (3, 31), and are located in the same cellular compartment. The different biochemical regulation of PanK1{beta} and PanK3 provided an explanation for their co-existence in the same tissues and suggest a mechanism for metabolic control over the CoA pool that is dependent on the relative expression levels of the PanK isoforms. For example, accumulation of long-chain fatty acyl CoAs, as with a high fat diet, would reduce the CoA levels in tissues that express PanK1{alpha} = PanK3 > PanK1{beta}, whereas tissues that express PanK1{beta} > PanK3 = PanK1{alpha} would likely have higher CoA under the circumstances, which may, in turn, promote fatty acid oxidation (27).

The distinct difference in the regulatory properties of the PanK1{beta} and PanK3 isoforms arises from the divergence at their amino termini. The proteins are 79% identical (Fig. 1), exhibit very similar biochemical activities (Fig. 2A) and kinetic constants, and have the same apparent oligomeric structure (Fig. 2B). Comparison of their predicted amino acid sequences (Fig. 1) suggested that residues 55–102 might encode a PanK3 region that mediates inhibition by palmitoyl CoA. This region was swapped between the two PanKs, and the results confirmed that this region in the catalytic domain of PanK3 was necessary for interaction with long- and short-chain CoA thioesters (Fig. 7). Previously, we showed that PanK1{alpha} possesses a 184-amino-terminal extension that confers increased regulation by CoA thioesters onto PanK1{beta} (5). PanK1{alpha} and PanK1{beta} arise from the same gene via different initiation exons, and the catalytic cores of these two proteins are identical (5, 32). The CoA interaction domain identified in PanK3 suggest a structurally different mechanism for regulation when compared with PanK1{alpha} since it is intrinsic to the catalytic core of the protein.

These data addressing the relative expression levels of the PanKs must be viewed as a snapshot of the isoform distribution under the specific conditions of the experiments. Tissues modulate their CoA levels in response to diet and disease, and these changes are tied to fluctuations in the level of total PanK activity. The metabolic state of the animal (fasting or feeding) (15–19), pathological conditions (diabetes) (23, 24), and hypolipidemic drugs (fibrates) (14, 19, 20) all significantly alter the cellular levels of CoA. These alterations are reflected in concomitant changes in tissue PanK activity (21, 22), indicating an important role for PanK expression in controlling the cellular CoA levels. Extracts from livers derived from animals treated with hypolipidemic drugs not only have increased PanK activity, but also, this elevated activity responds differently to CoA and acetyl-CoA regulators when compared with the activity from control livers (8), thus suggesting selective expression of PanK isoforms induced by the drug. In those early experiments, the existence of multiple PanK isoforms was not appreciated, but recently, human PanK1{alpha} isoform expression was demonstrated to be responsive to stimulation of PPAR{alpha} transcriptional activity in HepG2 cells (43). Thus, the mix of PanKs that are expressed in mammalian tissues will likely differ significantly depending not only on the tissue but also on the nutritional or pharmacological state and perhaps on gender. The composition of the homogeneous growth media used in culture models may also influence the cells to express a constellation of PanK isoforms different from the tissues from which they were derived.


   FOOTNOTES
 
* This work was supported by National Institutes of Health Grant GM62896, Cancer Center (CORE) Support Grant CA 21765, and a grant from the American Lebanese Syrian Associated Charities. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact. Back

1 To whom correspondence should be addressed: Dept. of Infectious Diseases, St Jude Children's Research Hospital, 332 N. Lauderdale, Memphis, TN 38105-2794. Tel.: 901-495-3494; Fax: 901-495-3099; E-mail: suzanne.jackowski{at}stjude.org.

2 The abbreviations used are: CoA, coenzyme A; PanK, pantothenate kinase; RT-PCR, real-time PCR. Back


   ACKNOWLEDGMENTS
 
We thank Daren Hemingway, Pam Jackson, Karen Miller, and Jina Wang for expert technical assistance.



   REFERENCES
TOP
 ABSTRACT
 INTRODUCTION
 EXPERIMENTAL PROCEDURES
 RESULTS
 DISCUSSION
 REFERENCES
 

  1. Jackowski, S., and Rock, C. O. (1981) J. Bacteriol. 148, 926–932[Abstract/Free Full Text]
  2. Robishaw, J. D., Berkich, D. A., and Neely, J. R. (1982) J. Biol. Chem. 257, 10967–10972[Abstract/Free Full Text]
  3. Rock, C. O., Calder, R. B., Karim, M. A., and Jackowski, S. (2000) J. Biol. Chem. 275, 1377–1383[Abstract/Free Full Text]
  4. Song, W.-J., and Jackowski, S. (1992) J. Bacteriol. 174, 6411–6417[Abstract/Free Full Text]
  5. Rock, C. O., Karim, M. A., Zhang, Y.-M., and Jackowski, S. (2002) Gene (Amst.) 291, 35–43[CrossRef][Medline] [Order article via Infotrieve]
  6. Song, W.-J., and Jackowski, S. (1994) J. Biol. Chem. 269, 27051–27058[Abstract/Free Full Text]
  7. Stolz, L. E., Huynh, C. V., Thorner, J., and York, J. D. (1998) Genetics 148, 1715–1729[Abstract/Free Full Text]
  8. Halvorsen, O., and Skrede, S. (1982) Eur. J. Biochem. 124, 211–215[Medline] [Order article via Infotrieve]
  9. Rock, C. O., Park, H.-W., and Jackowski, S. (2003) J. Bacteriol. 185, 3410–3415[Abstract/Free Full Text]
  10. Leonardi, R., Chohnan, S., Zhang, Y.-M., Virga, K. G., Lee, R. E., Rock, C. O., and Jackowski, S. (2005) J. Biol. Chem. 280, 3314–3322[Abstract/Free Full Text]
  11. delCardayre, S. B., Stock, K. P., Newton, G. L., Fahey, R. C., and Davies, J. E. (1998) J. Biol. Chem. 273, 5744–5751[Abstract/Free Full Text]
  12. delCardayre, S. B., and Davies, J. E. (1998) J. Biol. Chem. 273, 5752–5757[Abstract/Free Full Text]
  13. Luba, J., Charrier, V., and Claiborne, A. (1999) Biochemistry 38, 2725–2737[CrossRef][Medline] [Order article via Infotrieve]
  14. Voltti, H., Savolainen, M. J., Jauhonen, V. P., and Hassinen, I. E. (1979) Biochem. J. 182, 95–102[Medline] [Order article via Infotrieve]
  15. Smith, C. M., and Savage, C. R., Jr. (1980) Biochem. J. 188, 175–184[Medline] [Order article via Infotrieve]
  16. Smith, C. M., Cano, M. L., and Potyraj, J. (1978) J. Nutr. 108, 854–862[Abstract/Free Full Text]
  17. Kondrup, J., and Grunnet, N. (1973) Biochem. J. 132, 373–379[Medline] [Order article via Infotrieve]
  18. Lund, H., Stakkestad, J. A., and Skrede, S. (1986) Biochim. Biophys. Acta 876, 685–687[Medline] [Order article via Infotrieve]
  19. Savolainen, M. J., Jauhonen, V. P., and Hassinen, I. E. (1977) Biochem. Pharmacol. 26, 425–431[CrossRef][Medline] [Order article via Infotrieve]
  20. Bhuiyan, A. K. M. J., Bartlett, K., Sherratt, H. S. A., and Agius, L. (1988) Biochem. J. 253, 337–343[Medline] [Order article via Infotrieve]
  21. Skrede, S., and Halvorsen, O. (1979) Eur. J. Biochem. 98, 223–229[Medline] [Order article via Infotrieve]
  22. Halvorsen, O. (1983) Biochem. Pharmacol. 32, 1126–1128[CrossRef][Medline] [Order article via Infotrieve]
  23. Reibel, D. K., Wyse, B. W., Berkich, D. A., Palko, W. M., and Neely, J. R. (1981) Am. J. Physiol. 240, E597–E601
  24. Reibel, D. K., Wyse, B. W., Berkich, D. A., and Neely, J. R. (1981) Am. J. Physiol. 240, H606–H611
  25. Idell-Wenger, J., Grotyohann, L., and Neely, J. R. (1978) J. Biol. Chem. 253, 4310–4318[Abstract/Free Full Text]
  26. Williamson, J., and Corkey, B. (1979) Methods Enzymol. 55, 200–222[Medline] [Order article via Infotrieve]
  27. Wang, H.-Y., Baxter, C. F., and Schulz, H. (1991) Arch. Biochem. Biophys. 289, 274–280[CrossRef][Medline] [Order article via Infotrieve]
  28. Horie, S., Isobe, M., and Suga, T. (1986) J. Biochem. 99, 1345–1352[Abstract/Free Full Text]
  29. Van Broekhoven, A., Peeters, M.-C., Debeer, L. J., and Mannaerts, G. P. (1981) Biochem. Biophys. Res. Commun. 100, 305–312[CrossRef][Medline] [Order article via Infotrieve]
  30. Van Veldhoven, P. P., and Mannaerts, G. P. (1986) Biochem. Biophys. Res. Commun. 139, 1195–1201[CrossRef][Medline] [Order article via Infotrieve]
  31. Zhou, B., Westaway, S. K., Levinson, B., Johnson, M. A., Gitschier, J., and Hayflick, S. J. (2001) Nat. Genet. 28, 345–349[CrossRef][Medline] [Order article via Infotrieve]
  32. Ramaswamy, G., Karim, M. A., Murti, K. G., and Jackowski, S. (2004) J. Lipid Res. 45, 17–31[Abstract/Free Full Text]
  33. Hortnagel, K., Prokisch, H., and Meitinger, T. (2003) Hum. Mol. Genet. 12, 321–327[Abstract/Free Full Text]
  34. Ni, X., Ma, Y., Cheng, H., Jiang, M., Ying, K., Xie, Y., and Mao, Y. (2002) Int. J. Biochem. Cell Biol. 34, 109–115[CrossRef][Medline] [Order article via Infotrieve]
  35. Eppig, J. T., Bult, C. J., Kadin, J. A., Richardson, J. E., Blake, J. A., Anagnostopoulos, A., Baldarelli, R. M., Baya, M., Beal, J. S., Bello, S. M., Boddy, W. J., Bradt, D. W., Burkart, D. L., Butler, N. E., Campbell, J., Cassell, M. A., Corbani, L. E., Cousins, S. L., Dahmen, D. J., Dene, H., Diehl, A. D., Drabkin, H. J., Frazer, K. S., Frost, P., Glass, L. H., Goldsmith, C. W., Grant, P. L., Lennon-Pierce, M., Lewis, J., Lu, I., Maltais, L. J., McAndrews-Hill, M., McClellan, L., Miers, D. B., Miller, L. A., Ni, L., Ormsby, J. E., Qi, D., Reddy, T. B., Reed, D. J., Richards-Smith, B., Shaw, D. R., Sinclair, R., Smith, C. L., Szauter, P., Walker, M. B., Walton, D. O., Washburn, L. L., Witham, I. T., and Zhu, Y. (2005) Nucleic Acids Res. 33, D471-D475[Abstract/Free Full Text]
  36. Kotzbauer, P. T., Truax, A. C., Trojanowski, J. Q., and Lee, V. M. Y. (2005) J. Neurosci. 25, 689–698[Abstract/Free Full Text]
  37. Johnson, M. A., Kuo, Y. M., Westaway, S. K., Parker, S. M., Ching, K. H., Gitschier, J., and Hayflick, S. J. (2004) Ann. N. Y. Acad. Sci. 1012, 282–298[CrossRef][Medline] [Order article via Infotrieve]
  38. Thomas, M., Hayflick, S. J., and Jankovic, J. (2004) Movement Disorders 19, 36–42
  39. Kuo, Y. M., Duncan, J. L., Westaway, S. K., Yang, H., Nune, G., Xu, E. Y., Hayflick, S. J., and Gitschier, J. (2005) Hum. Mol. Genet. 14, 49–57[Abstract/Free Full Text]
  40. Bradford, M. M. (1976) Anal. Biochem. 72, 248–254[CrossRef][Medline] [Order article via Infotrieve]
  41. Jackowski, S. (1994) J. Biol. Chem. 269, 3858–3867[Abstract/Free Full Text]
  42. Karim, M., Jackson, P., and Jackowski, S. (2003) Biochim. Biophys. Acta 1633, 1–12[Medline] [Order article via Infotrieve]
  43. Yang, D., Chen, Q., Hoover, D. M., Staley, P., Tucker, K. D., Lubkowski, J., and Oppenheim, J. J. (2003) J. Leukocyte Biol. 74, 448–455[Abstract/Free Full Text]

Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
 J. Biol. Chem.Home page
B. S. Hong, G. Senisterra, W. M. Rabeh, M. Vedadi, R. Leonardi, Y.-M. Zhang, C. O. Rock, S. Jackowski, and H.-W. Park
Crystal Structures of Human Pantothenate Kinases: INSIGHTS INTO ALLOSTERIC REGULATION AND MUTATIONS LINKED TO A NEURODEGENERATION DISORDER
J. Biol. Chem., September 21, 2007; 282(38): 27984 - 27993.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
R. Leonardi, C. O. Rock, S. Jackowski, and Y.-M. Zhang
Activation of human mitochondrial pantothenate kinase 2 by palmitoylcarnitine
PNAS, January 30, 2007; 104(5): 1494 - 1499.
[Abstract] [Full Text] [PDF]

Home page
 J. Nutr.Home page
M. H. Stipanuk, J. E. Dominy Jr., J.-I. Lee, and R. M. Coloso
Mammalian Cysteine Metabolism: New Insights into Regulation of Cysteine Metabolism
J. Nutr., June 1, 2006; 136(6): 1652S - 1659S.
[Abstract] [Full Text] [PDF]

Home page
 EndocrinologyHome page
B. P. Schimmer, M. Cordova, H. Cheng, A. Tsao, A. B. Goryachev, A. D. Schimmer, and Q. Morris
Global Profiles of Gene Expression Induced by Adrenocorticotropin in Y1 Mouse Adrenal Cells
Endocrinology, May 1, 2006; 147(5): 2357 - 2367.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
Y.-M. Zhang, C. O. Rock, and S. Jackowski
Biochemical Properties of Human Pantothenate Kinase 2 Isoforms and Mutations Linked to Pantothenate Kinase-associated Neurodegeneration
J. Biol. Chem., January 6, 2006; 281(1): 107 - 114.
[Abstract] [Full Text] [PDF]

This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
280/38/32594    most recent
M506275200v1
Right arrow Submit a Letter to Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Zhang, Y.-M.
Right arrow Articles by Jackowski, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Zhang, Y.-M.
Right arrow Articles by Jackowski, S.
Social Bookmarking
Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 2005 by the American Society for Biochemistry and Molecular Biology.
Advertisement
spacer
Advertisement
Advertisement